Recurrent Upper Gastrointestinal Bleeding in a Young Ugandan Man with Grade III Esophageal Varices and Peptic Ulcer Disease: A Case Report
This case report describes a 28-year-old Ugandan man with recurrent upper gastrointestinal bleeding caused by concurrent Grade III esophageal varices and peptic ulcer disease, highlighting the diagnostic complexity of overlapping etiologies in sub-Saharan Africa and the importance of comprehensive endoscopic evaluation and targeted management.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When the upper part of the digestive tract begins to bleed, it is a medical emergency that demands immediate attention. This area, which includes the esophagus, stomach, and the beginning of the small intestine, can lose blood through several different pathways. Sometimes, the lining of the stomach becomes irritated or eroded, creating sores known as ulcers that bleed. Other times, the veins in the esophagus become dangerously swollen and burst. These swollen veins, called varices, usually happen because pressure builds up in the liver's blood vessels, forcing blood to find alternative routes through the esophagus. In many parts of the world, this pressure is caused by liver disease from alcohol or viruses, but in some regions, it stems from other infections that scar the liver without destroying it entirely. Distinguishing between a bleeding ulcer and a bursting vein is critical because the treatments for each are different, yet the symptoms—vomiting blood or passing black, tarry stools—can look exactly the same.
In a recent report from Uganda, a team of doctors shared the story of a twenty-eight-year-old man who faced this exact dilemma. He worked as a fuel pump attendant and arrived at a regional hospital vomiting large amounts of blood and passing black stool, symptoms that had first appeared three months earlier. During that first visit, doctors had used a flexible camera to look inside his stomach and found two things: inflammation of the stomach lining and severe swelling of the veins in his esophagus, classified as grade three, which is the most serious level. Despite this finding, the young man had no history of alcohol use, no known liver disease, and showed none of the usual physical signs of a failing liver, such as yellowing skin or fluid in the belly. He had simply been treated with fluids, antibiotics, and blood transfusions and sent home. Now, three months later, the bleeding had returned with the same intensity, bringing with it severe weakness, dizziness, and burning pain in his upper abdomen.
The medical team treated him as a patient with a severe upper gastrointestinal bleed, a condition where blood loss can quickly become life-threatening. They started him on intravenous fluids to restore his volume and gave him a blood transfusion to replace what he had lost. To calm the stomach and stop acid from making any potential sores worse, they administered a strong acid-blocking medicine. They also gave him antibiotics to prevent infection, a standard precaution for this type of emergency. On the second day of his stay, they added a medication called tranexamic acid, which is designed to help blood clot faster. Over the next three days, the man's condition improved. The black stool turned yellow, his vital signs stabilized, and his weakness began to lift. He was alert, his pain decreased, and he appeared to be recovering from the acute crisis.
However, the report highlights a significant gap in the medical record that leaves the true cause of the bleeding uncertain. While the doctors had seen the swollen veins three months prior, they did not perform a new camera examination during this second admission to confirm whether the veins had bled again or if a new ulcer was the culprit. Because the source of the bleeding was never visually confirmed during this specific episode, the doctors could not be sure if the treatment was perfectly targeted. Furthermore, the report points out that the use of tranexamic acid in this case was not supported by the best available global evidence. A massive international study involving thousands of patients with gastrointestinal bleeding had previously shown that this drug does not save lives in such cases and may actually increase the risk of dangerous blood clots. The patient's recovery in this instance was likely due to the combination of fluids, blood, and acid suppression, rather than the clotting medication.
This case serves as a reminder that in young patients, serious internal bleeding can occur even without the classic signs of chronic liver disease. The presence of swollen veins in the esophagus, once found, should never be ignored, even if the patient looks healthy otherwise. The report underscores that when bleeding returns, doctors must quickly stabilize the patient and then use a camera to see exactly where the blood is coming from, rather than guessing based on symptoms alone. It also suggests that medical teams should be cautious about using certain clotting drugs unless they are part of a specific research study, as the evidence does not yet support their routine use for this type of emergency. The story of this young man illustrates the complex challenge of managing recurrent bleeding when the underlying cause remains a mystery, emphasizing the need for careful observation and definitive testing to guide future care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.